In an informative article, Neale and colleagues report the experiences of more than 3 dozen people who were equipped with take-home naloxone (THN) and trained in overdose response at syringe service programs in New York City [1] . These individuals, all of whom reported current or recent heroin injection, proved highly capable of responding appropriately to overdose emergencies, including identifying a probable opioid overdose, administering naloxone and providing post-overdose care. In nearly 75% of cases, they also called emergency services. These findings highlight what decades of practice and research evidence have shown: people who use drugs (PWUD) are both willing and able to reduce risk of drug-related harm for themselves and others. They also suggest paths forward for harm reduction policy in the United States.
First, this report highlights the importance of rapidly scaling-up THN programs and preferentially directing naloxone distribution efforts towards PWUD. According to recent data from the US Centers for Disease Control and Prevention, bystanders were present at nearly 45% of fatal opioid overdoses, but naloxone was administered by laypeople in fewer than 4% of cases [2] . It is likely that this is largely because, despite recent increases in the number of THN programs, legal changes to enable greater pharmacy access and efforts to equip non-medical uniformed responders with the medication, naloxone access is still drastically insufficient to meet the unprecedented rise in opioid overdose [3] [4] [5] [6] .
Any increase in naloxone availability is a net positive, but in an environment of limited resources attention should be focused first on PWUD, who are in many instances the first-and in some cases the only-individuals to provide emergency overdose care. Indeed, recent research has shown that PWUD deploy THN naloxone at a rate nearly 10 times that of non-PWUD laypeople [7] . Particularly now that illicitly manufactured fentanyl has infiltrated the heroin supply throughout much of the United States, it is imperative that policy, practice and funding focus first on equipping these overdose first responders with the naloxone they can use to save lives [8] .
These findings also have important implications for policy and practice regarding two emerging interventions both in the United States and abroad: the distribution of fentanyl test strips (FTS) to PWUD and the expansion and legalization of supervised consumption spaces (SCS). Both interventions create conditions that enable PWUD to reduce the harms associated with their drug use, and both are supported by emerging or established evidence [9] [10] [11] [12] .
Unlike the relatively rapid adoption of laws to increase access to naloxone in the United States, both SCS and FTS remain hampered by stigma-rooted barriers [13, 14] . For example, the US Assistant Secretary for Mental Health and Substance Use recently questioned the utility of FTS by claiming that PWUD are not rational actors and would be unlikely to modify their behavior based on the results of FTS [15] . This opinion is not grounded in fact. Indeed, all available evidence suggests that PWUD will both utilize FTS and modify their behavior based on the results [11, 12, 16] .
Similarly, federal prosecutors continue to threaten cities and states that wish to open SCS with legal action, often while making outlandish claims regarding their potential effects, including that they do not reduce drug-related harm and that they 'attract drug dealers, sexual predators, and other criminals, ultimately destroying the surrounding community' [17] . There is no evidence for such claims; SCS reduce drug-related harm without negatively impacting public safety [9, 10] . Such falsehoods-which are based on stigma, not science-have no place in a modern society.
Finally, these results highlight the need to take seriously the goals and experiences of PWUD when designing and implementing harm reduction initiatives [18] . As Neale et al. note, '[o]pioid users who have personally responded to an overdose have valuable insights and experience and can play an important role in delivering THN programs …' [1] . This is true, but it does not go far enough. In addition to delivering naloxone and other services, PWUD must be given a leading role in the creation of both policy and programs affecting PWUD. If such roles are not given willingly, they must be taken. It is long past time that these decisions be made by the individuals affected, not politicians, clinicians and law enforcement officers who do not understand or actively dismiss the needs and rights of PWUD [19] .
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